Celebrating World Diabetes Day 2023

Access to Diabetes Care

The theme of World Diabetes Day 2023 is "Access to Diabetes Care". We support the millions of individuals managing diabetes and recognize the crucial and continuous research endeavours directed towards conquering the disease. Timely access to reliable information and adequate care is instrumental in ensuring swift treatment and successful disease management.

Elsevier empowers you with knowledge and valuable information to support the management of diabetes. On this World Diabetes Day 2023 we present some of the cutting-edge research published in our Endocrinology journals.

Enjoy free access to these articles until February 29, 2024.

Article collection

AACE Clinical Case Reports

• Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors abre em uma nova guia/janela

• Diabetic Ketoacidosis in a Patient With Type I Diabetes Treated With a Closed-Loop Sensor–Augmented Insulin Infusion System abre em uma nova guia/janela

Annales d'Endocrinologie

• Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes abre em uma nova guia/janela

• Epidemiology and health impact of diabetes in France abre em uma nova guia/janela

Best Practice & Research Clinical Endocrinology & Metabolism

• Genetics and epigenetics of autoimmune thyroid diseases: Translational implications abre em uma nova guia/janela

• Genomic and epigenomic profile of thyroid cancer abre em uma nova guia/janela

Bone

• Role of advanced glycation endproducts in bone fragility in type 1 diabetes abre em uma nova guia/janela

• Associations of estrogen therapy and non-estrogen anti-resorptive therapy with diabetes mellitus risk: A classical and Bayesian meta-analysis abre em uma nova guia/janela

Bone Reports

• Effects of empagliflozin on markers of calcium and phosphate homeostasis in patients with type 2 diabetes – Data from a randomized, placebo-controlled study abre em uma nova guia/janela

• Type 2 diabetes alters the viscoelastic behavior and macromolecular composition of vertebra abre em uma nova guia/janela

Canadian Journal of Diabetes

• Acceptability of Self-Management Group Education to Reduce Fear of Hypoglycemia as a Barrier to Physical Activity in Adults With Type 1 Diabetes: A Mixed Methods Approach abre em uma nova guia/janela

• Barriers to Physical Activity in Children and Adults Living With Type 1 Diabetes: A Complex Link With Real-life Glycemic Excursions abre em uma nova guia/janela

Current Opinion in Endocrine and Metabolic Research

• Designing next-generation islet-like cells from human pluripotent stem cells: Advances in overcoming allorejection and recurrent type 1 diabetes abre em uma nova guia/janela

• Clinical efficacy and mechanism of action of medical devices for obesity and type 2 diabetes abre em uma nova guia/janela

Cytokine and Growth Factor Reviews

• The roles of cell-cell and organ-organ crosstalk in the type 2 diabetes mellitus associated inflammatory microenvironment abre em uma nova guia/janela

• Growth differentiation factor-15 and its role in diabetes and cardiovascular disease abre em uma nova guia/janela

Diabetes Epidemiology and Management

• PRODIAB: Perspectives on the use of patient-reported outcome measures among diabetic patients abre em uma nova guia/janela

• Benefits and limitations of hypo/hyperglycemic alarms associated with continuous glucose monitoring in individuals with diabetes abre em uma nova guia/janela

Diabetes & Metabolism

• Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study abre em uma nova guia/janela

• Associations of MAFLD and MAFLD subtypes with the risk of the incident myocardial infarction and stroke abre em uma nova guia/janela

Diabetes and Metabolic Syndrome: Clinical Research & Reviews

• Empagliflozin improves quality of life in nondiabetic HFrEF patients. Sub-analysis of the EMPATROPISM trial abre em uma nova guia/janela

• Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A meta-analysis with the FREEDOM cardiovascular outcomes trial abre em uma nova guia/janela

Diabetes Research and Clinical Practice

• Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations abre em uma nova guia/janela

• Worldwide estimates of incidence of type 2 diabetes in children and adolescents in 2021 abre em uma nova guia/janela

Endocrinologia, Diabetes y Nutrición (English version)

• Metabolic control and treatment regimens in patients with type 1 diabetes in Castilla-La Mancha, 10 years later: The 2020 DIACAM1 study abre em uma nova guia/janela

• Epidemiology and resource use in Spanish type 2 diabetes patients without previous cardiorenal disease: CaReMe Spain study summary abre em uma nova guia/janela

Endocrinología, Diabetes y Nutrición

• Gestational diabetes prevalence and outcomes in women undergoing assisted reproductive techniques (ART)Prevalencia y resultados de la diabetes gestacional en mujeres sometidas a técnicas de reproducción asistida (TRA) abre em uma nova guia/janela

• Relationship between soluble protein ST2 (sST2) levels and microvascular complications in a cohort of patients with type 1 diabetes abre em uma nova guia/janela

Endocrine and Metabolic Science

• Associations between metabolic phenotypes and diabetes risk: A systematic review and meta-analysis abre em uma nova guia/janela

• The association of aldosterone and endothelin-1 with incident diabetes among African Americans: The Jackson Heart Study abre em uma nova guia/janela

Endocrine Practice

• American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update abre em uma nova guia/janela

• American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update abre em uma nova guia/janela

Growth Hormone & IGF Research

• Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis abre em uma nova guia/janela

• A consensus on optimization of care in patients with growth hormone deficiency and mild traumatic brain injury abre em uma nova guia/janela

Journal of Clinical and Translational Endocrinology

• Characteristics, staging and outcomes of differentiated thyroid cancer in patients with and without Graves’ disease abre em uma nova guia/janela

Journal of Clinical and Translational Endocrinology: Case Reports

• Hypertriglyceridemia in gestational diabetes: Case report and review of the literature abre em uma nova guia/janela

Journal of Clinical Densitometry

• Skin autofluorescence Is associated With low bone mineral density in type 2 diabetic patients abre em uma nova guia/janela

• Bone Metabolism Discrepancy in Type 2 Diabetes Mellitus Patients With and Without Non-Alcoholic Fatty Liver Disease abre em uma nova guia/janela

Journal of Diabetes and its complications

• Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes abre em uma nova guia/janela

• Frontiers in diabetic retinal disease abre em uma nova guia/janela

Metabolism

• Metformin: Is it a drug for all reasons and diseases? abre em uma nova guia/janela

• Insulin: The master regulator of glucose metabolism abre em uma nova guia/janela

Metabolism Open

• The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: A literature review abre em uma nova guia/janela

Molecular and Cellular Endocrinology

• Maternal diabetes increases FOXO1 activation during embryonic cardiac development abre em uma nova guia/janela

• Genetic basis of nephrogenic diabetes insipidus abre em uma nova guia/janela

Obesity Pillars

• Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023 abre em uma nova guia/janela

• Artificial intelligence and obesity management: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023 abre em uma nova guia/janela

Obesity Research and Clinical Practice

• Associations between obesity parameters and hyperuricemia by sex, age, and diabetes mellitus: A nationwide study in Korea abre em uma nova guia/janela

• Overweight and obese youth with type 1 or type 2 diabetes share similar elevation in triglycerides during middle and late adolescence abre em uma nova guia/janela

Peptides

• The molecular pharmacology of glucagon agonists in diabetes and obesity abre em uma nova guia/janela

• Pancreatic polypeptide revisited: Potential therapeutic effects in obesity-diabetes abre em uma nova guia/janela

Primary Care Diabetes

• A systematic review and meta-analysis to compare the prevalence of depression between people with and without Type 1 and Type 2 diabetes abre em uma nova guia/janela

• Association of community-level food insecurity and glycemic control among pregnant individuals with pregestational diabetes abre em uma nova guia/janela

Prostaglandins, Leukotrienes and Essential Fatty Acids

• Placental F4-Neuroprostanes and F2-Isoprostanes are altered in gestational diabetes mellitus and maternal obesity abre em uma nova guia/janela

• Omega-3 index and type 2 diabetes: Systematic review and meta-analysis abre em uma nova guia/janela

Steroids

• Vascular endothelial dysfunction in gestational diabetes mellitus abre em uma nova guia/janela

• Protective effects of combining SERMs with estrogen on metabolic parameters in postmenopausal diabetic cardiovascular dysfunction: The role of cytokines and angiotensin II abre em uma nova guia/janela

The Journal of Steroid Biochemistry and Molecular Biology

• Effects of long-term vitamin D supplementation on metabolic profile in middle-aged and elderly patients with type 2 diabetes abre em uma nova guia/janela

• The effects of 1,25(OH)2D3 treatment on metabolic reprogramming and maturation in bone marrow-derived dendritic cells from control and diabetic mice abre em uma nova guia/janela